Mnemosyne Pharmaceuticals

Developer of small molecule therapeutics for neuropsychiatric conditions

placeProvidence, Rhode Island, United States calendar_todayFounded 2010 groups4 employees language mnemosynepharma.com

Innovation

3 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 90 times.

YearFilings
20152
20163
20172

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital3100%
Coming soon